Investors

EASTGATE BIOTECH ENGAGES AGENT TO IDENTIFY SUITABLE JOINT VENTURE PARTNERS AND SUPPLIERS IN THE PHILIPPINES

May 15, 2017 by admin

The agent, Roger Munoz, a principal of i-Power Philippines, a subsidiary of the ICube Group (www.icube.ph) a large holding group mostly for Nippon SME business in the Philippines, will work together with the company’s own Global Business Development team to act in EastGate’s interests

Read more

Eastgate Biotech Business Turnaround Expert Bill Abajian On The Positive Stocks Investor Influence Network

April 29, 2017 by admin

Mr. William (Bill) D. Abajian brings over 30 years experience in the pharmaceutical and biotechnology industry. He started his career at Electro Nucleonics Inc. in Fairfield, New Jersey where he served as the Vice President of Sales and Marketing between 1981-1988.

Read more

Eastgate Biotech Corp., Engages Gunpowder Capital Corp.

April 25, 2017 by admin

Toronto, Ontario, April 25th, 2017 – Gunpowder Capital Corp., (CSE: GPC), (CSE: GPC.PR.A), (Frankfurt: YS6N), (“Gunpowder”, “GPC” or the “Corporation”) announced today that entered into various agreements with Eastgate Biotech Corp., (OTCPink: ETBI) (“Eastgate”).

Read more

EASTGATE BIOTECH’S RECENT ACQUISITION OMNI SURGERY + ANTI-AGING CENTRE APPOINTS DR. ISHAAN SUNDAR AS MEDICAL DIRECTOR

April 12, 2017 by admin

Dr. Ishaan Sundar has assumed the role of Medical Director effective immediately. Educated by the American Academy of Aesthetic Medicine, American Cosmetic Cellular Medicine Association, Laser Sheer Training Academy and trained in Injectable Placements, Dr. Sundar brings over 20 years of extensive practice to the OMNI state-of-the-art centre.

Read more

EASTGATE BIOTECH CORPORATION AND AC NOVA TECHNOLOGIES (ATI PHARMA) ANNOUNCE A JOINT VENTURE

April 7, 2017 by admin

PHARMACEUTICAL BIOTECH RESEARCH COMPANY EASTGATE BIOTECH CORPORATION AND AC NOVA TECHNOLOGIES (ATI PHARMA) ANNOUNCE A JOINT VENTURE TO COMMERCIALIZE EVIDENCE-BASED NATURAL THERAPIES FOCUSED ON GLUCOSE BALANCE AND CARDIOVASCULAR HEALTH

Read more

Purchase and Sale Agreement to acquire Omni Surgery and Anti-Aging Centre

March 14, 2017 by admin

EastGate Biotech Corp.has entered into a Purchase and Sale Agreement to acquire OMNI Surgery and Anti-Aging Centre.

Read more

EASTGATE BIOTECH FEATURED ON UPTICK NEWSWIRE

July 11, 2016 by admin

WEST CALDWELL, NJ and TORONTO, July 11, 2016 (GlobeNewsire/-) EastGate Biotech Corp. (Pink Sheets: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has announced that CEO Anna Gluskin recently completed an interview with Mr. Everett Jolly from Uptick Newswire.

Read more

EASTGATE BIOTECH ANNOUNCES THAT IT HAS RECEIVED A SUBSTANTIAL ORDER FOR GLUCORA, ITS NATURAL GLUCOSE MANAGEMENT PRODUCT

May 2, 2016 by admin

We are pleased that we have received our first material order for Glucora” says Anna Gluskin, EastGate Biotech’s CEO. “We believe that Glucora is a product with mass market appeal and will play a key role in the company’s diabetes franchise.

Read more

Eastgate Biotech CEO Anna Gluskin talks to ‘TheStockRadio.com’ about their products and delivery technology

February 8, 2016 by admin

We look forward to introducing the benefits of such delivery, that is now available through our nutraceutical products currently being sold on the market, to a larger audience” continues Gluskin.

Read more
RSS Icon